📇 Rhumatologue · POITIERS CEDEX · (86) · Mixte

MME DELPHINE MOREAU

Pourquoi vous devez consulter ce praticien

6 raisons identifiées

Plateau technique de référence
Centre hospitalier universitaire (CHU) — équipements et expertise pointus pour les cas complexes
Auteur de référence en rhumatologie
20 articles scientifiques publiés — un praticien à la pointe de la recherche
Encadrant universitaire
Forme la prochaine génération de rhumatologues (1 thèse dirigée)
Expérience confirmée
19 ans d'exercice en rhumatologie — recul clinique solide
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
124.6 rhumatos / 100 000 hab. — département bien doté

Rhumatologue

📍 POITIERS CEDEX (86)MixteRPPS 10004389978

Expérience confirmée

19ans d'exercice (thèse 2007)

📊 Reconnaissance scientifique : 31/100📝 248 articles publiés🇫🇷 Publications académiques françaises (8)🎓 1 thèse dirigée

✨ Génération du profil synthétique IA en cours…

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.

Top publications · les plus citées

Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2005

📚 216 citations🎯 RCR 4.86Top 8% NIH

Lire l'abstract Crossref ↓

Purpose To evaluate the outcome of cancer patients considered for admission to the intensive care unit (ICU). Patients and Methods Prospective, one-year hospital-wide study of all cancer and hematology patients, including bone marrow transplantation patients, for whom admission to the ICU was requested. Results Of the 206 patients considered for ICU admission, 105 patients (51%) were admitted. Of the 101 patients who were not admitted, 54 patients (26.2%) were considered too sick to benefit, and 47 patients (22.8%) were considered to be too well to benefit from the ICU. Of these 47 patients, 13 patients were admitted later. Survival rates after 30 and 180 days were significantly associated with admission status (P < .0001). Remission of the malignancy (odds ratio [OR], 3.37; 95% CI, 1.25 to 9.07) was independently associated with ICU admission, whereas poor chronic health status (OR, 0.38; 95% CI, 0.16 to 0.74) and solid tumor (OR, 0.43; 95% CI, 0.24 to 0.78) were associated with ICU refusal. In admitted patients, 30-day and 6-month survival rates were 54.3% and 32.4%, respectively. Of the patients considered too sick to benefit from ICU admission, 26% were alive on day 30 and 16.7% on day 180. Among patients considered too well to benefit, the 30-day survival rate was a worrisome 78.7%. Calibration of the Mortality Probability Model (the only score available at triage) was of limited value for predicting 30-day survival (area under the curve, 0.62). Conclusion Both the excess mortality in too-well patients later admitted to the ICU and the relatively good survival in too-sick patients suggest the need for a broader admission policy.

The prognosis of acute respiratory failure in critically ill cancer patients

Medicine · 2004

📚 209 citations🎯 RCR 5.15Top 7% NIH

Improved survival of critically ill cancer patients with septic shock

Intensive care medicine · 2003

📚 192 citations🎯 RCR 4.94Top 8% NIH

Cookies & analyse de trafic

MME DELPHINE MOREAU

Pourquoi vous devez consulter ce praticien

Thèses universitaires

Direction de thèses

Activité de recherche & publications

Publications académiques en France

Lieux de consultation(2)

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Top publications · les plus citées

Publications scientifiques (20) — classées par pathologie

Transversal16

Pédiatrie2

Activité physique / Rééducation1

Essai clinique1

Datasets & protocoles partagés

Partager cette fiche